Live cultures are sensitive. Heat, humidity, and long storage times take their toll, and this is precisely where postbiotic supplements come in. These are heat-treated, no longer living microbial preparations that do not require refrigeration. According to a new analysis by Future Market Insights (FMI), global sales of these products will increase from USD 14.5 million in 2026 to USD 44.2 million in 2036. This corresponds to a compound annual growth rate (CAGR) of 11.8 percent. In 2025, the volume was around USD 13.0 million.
Compared to related categories, the market is still small. Probiotic supplements market are worth billions. This is precisely why it’s worth examining the dynamics: The switch from live cultures to heat-treated formats is likely to happen gradually, product line by product line, and initially in those areas where maintaining a guaranteed bacterial count is most difficult.
Europe is growing faster than the global market.
The two European countries in the FMI forecast are at the top. Great Britain is projected to achieve a CAGR of 13.8 percent, followed by Germany at 13.2 percent. Both are thus clearly above the global average. Japan is growing at 11.9 percent, roughly in line with the overall market, while the USA at 9.5 percent and South Korea at 8.5 percent bring up the rear. There is a difference of 5.3 percentage points between the fastest and slowest countries.
For Germany, FMI sees pharmacies as the crucial channel. Buyers expect robust documentation before a microbiome product is listed. Health-related claims are subject to the EU regulatory framework and may only be used in approved wording. According to analysts, the speed at which brands compile this documentation will determine the pace of growth in Germany.
The market is growing in the UK, even though regulations are still evolving. The Food Standards Agency published updated guidance for food supplements in June 2026. In September 2026, the industry body HFMA called for the use of the term „probiotic" on packaging, as eleven EU countries already do. If this change is implemented, the distinction between live and heat-treated products would become clearer on store shelves.
Within the EU, FMI anticipates demand will increase from USD 4.5 million (2026) to USD 14.3 million (2036), representing a CAGR of 12.3 percent. Further details on the EU forecast can be found in the analysis of Postbiotic Supplements Demand in EU.
Capsules in the foreground, online retail as the most important channel
By dosage form, capsules and tablets will account for approximately 55.6 percent of sales in 2026. The reason is practical: a fixed, standardized dose shows at a glance how much of a particular preparation is contained in each serving. In addition, contract manufacturers already operate encapsulation plants for probiotics, and brands can add postbiotic products to their portfolios without having to build new filling lines. Chewable formats such as gummies are gaining importance as a second form.
Online retailers lead in sales with 41.2 percent. Many buyers encounter the term „postbiotic" for the first time on a product page and confuse it with „probiotic." Online retailers have the space to explain preparation, dosage, and current research. Subscriptions also ensure repeat orders. Pharmacies and drugstores, health and beauty retailers, and modern grocery stores follow behind.
Competition: Human data relating to a specific preparation is crucial.
The market for named postbiotic preparations is concentrated among a few biotic specialists. Companies profiled by FMI include DSM-Firmenich, Novonesis, Kerry Group, Lallemand, Probi, and Kirin Holdings. In May 2026, Probi launched its first postbiotic preparation, Rham271h, at Vitafoods Europe. The company has been part of the German Symrise Group since 2025. Lallemand has been distributing the heat-inactivated strain IMMUSE, developed by Kirin, since May 2025. DSM-Firmenich now offers Humiome Post LB in an allergen-free version for rubber applications.
The biggest hurdle remains regulation. The scientific term „postbiotic" does not constitute a separate regulatory category. Companies selling in multiple countries must submit separate documentation for each. Japan has applied GMP-based manufacturing controls to food supplements with functional claims since September 1, 2026, while South Korea only permits recognized functions on the label. According to FMI’s assessment, the qualification costs primarily affect smaller brands seeking to enter multiple markets simultaneously.
“Postbiotic supplements will evolve from a niche gut health supplement to a mainstream option as consumers seek proven benefits without the storage and survival limitations of live probiotics,” says Nandini Roy Choudhury, Principal Consultant at Future Market Insights. “The greatest opportunity lies in clinically backed strains for immune, digestive, and metabolic support sold through online channels. Suppliers investing in strain-specific research and country-specific approvals for health claims will hold the most valuable positions through 2036.”
The full report covers seven regions and 27 countries or country groups, segmenting the market by dosage form and distribution channel. A free Sample Report available @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11655" can be requested directly.
About Future Market Insights
Future Market Insights, Inc. (FMI) is an ESOMAR-certified market research and consulting firm headquartered in Delaware, USA, with offices in the UK, UAE, and India. FMI produces syndicated and custom studies for companies in the food and beverage, healthcare, chemical, technology, packaging, and industrial sectors.
Press contact
Future Market Insights, Inc.
3rd Floor, 207 Regent Street, London W1B 3HH, United Kingdom
Telephone: +44 20 3769 9709
Email: sales@futuremarketinsights.com
Veröffentlicht von:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401,
19713 Newark
Vereinigte Staaten
Telefon: +1-347-918-3531
Homepage: https://www.futuremarketinsights.com/
Ansprechpartner(in): Rahul Singh
Herausgeber-Profil öffnen
Social Media:
Firmenprofil:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Delaware, USA, and has its global delivery center in India. In addition to these, FMI also carries out business development and client engagement through its UK and UAE offices.Informationen sind erhältlich bei:
Future Market Insights, Inc.T: +1-347-918-3531
Email: sales@futuremarketinsights.com
















